Cargando…

Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy

Detalles Bibliográficos
Autores principales:	Im, Ji Hye, Kang, Keon Wook, Kim, Sun Young, Kim, Yoon Gyoon, An, Yong Jin, Park, Sunghyouk, Jung, Byung Hwa, Choi, Song-Yi, Lee, Jin-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112569/ https://www.ncbi.nlm.nih.gov/pubmed/35581622 http://dx.doi.org/10.1186/s13046-022-02388-0

Ejemplares similares

GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy
por: Im, Ji Hye, et al.
Publicado: (2018)

Lactate as a major epigenetic carbon source for histone acetylation via nuclear LDH metabolism
por: An, Yong Jin, et al.
Publicado: (2023)

Microbial biotransformation to obtain stilbene methylglucoside with GPR119 agonistic activity
por: Peng, Yu, et al.
Publicado: (2023)

Oleoylethanolamide Exhibits GPR119-Dependent Inhibition of Osteoclast Function and GPR119-Independent Promotion of Osteoclast Apoptosis
por: Kim, Hyun-Ju, et al.
Publicado: (2020)

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
por: Kim, So Ra, et al.
Publicado: (2013)

Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
por: Tyurenkov, Ivan N., et al.
Publicado: (2018)

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021)

β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation
por: Panaro, Brandon L., et al.
Publicado: (2017)

DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
por: Kim, Youjin, et al.
Publicado: (2022)

Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119
por: Park, Eun-Young, et al.
Publicado: (2016)

Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor
por: Ansarullah,, et al.
Publicado: (2013)

GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
por: Zúñiga-Romero, Ángel, et al.
Publicado: (2022)

ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats
por: Tyurenkov, Ivan N., et al.
Publicado: (2017)

Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists
por: Fang, Yuanying, et al.
Publicado: (2019)

Potential Metabolic and Behavioural Roles of the Putative Endo- cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
por: Ramírez-Orozco, Ricardo E., et al.
Publicado: (2019)

The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo
por: Huan, Yi, et al.
Publicado: (2017)

Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
por: McKillop, Aine M., et al.
Publicado: (2016)

OR24-01 Mutational Study of the GPR119 Receptor Binding Site
por: Rosales, Matthew D, et al.
Publicado: (2020)

Activation and signaling mechanism revealed by GPR119-G(s) complex structures
por: Qian, Yuxia, et al.
Publicado: (2022)

History and Organizations for Radiological Protection
por: Kang, Keon Wook
Publicado: (2016)

Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
por: Ning, Y, et al.
Publicado: (2008)

Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells
por: Kim, Hyo Seon, et al.
Publicado: (2017)

CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy
por: Kim, Soo Jin, et al.
Publicado: (2022)

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023)

Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal Responses
por: Cox, Helen M., et al.
Publicado: (2010)

Intestinal GPR119 activation by microbiota-derived metabolites impacts feeding behavior and energy metabolism
por: Igarashi, Miki, et al.
Publicado: (2022)

Anti-Cancer Effects of CKD-581, a Potent Histone Deacetylase Inhibitor against Diffuse Large B-Cell Lymphoma
por: Kim, Soo Jin, et al.
Publicado: (2020)

Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies
por: Nunez, Derek J., et al.
Publicado: (2014)

Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science
por: Son, So-Eun, et al.
Publicado: (2021)

Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A
por: Kang, Changyu, et al.
Publicado: (2022)

Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT
por: Jin, Yujin, et al.
Publicado: (2019)

Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells
por: Hodge, Daryl, et al.
Publicado: (2016)

Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa
por: Tough, Iain R, et al.
Publicado: (2018)

Formation of βTC3 and MIN6 Pseudoislets Changes the Expression Pattern of Gpr40, Gpr55, and Gpr119 Receptors and Improves Lysophosphatidylcholines-Potentiated Glucose-Stimulated Insulin Secretion
por: Drzazga, Anna, et al.
Publicado: (2020)

Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model
por: Park, Bi-Oh, et al.
Publicado: (2022)

$^{119}$Sn Mössbauer study of the implantation behaviour of $^{119}$In, $^{119}$Sn, $^{119m}$Sn, $^{119}$Sb and $^{119m}$Te ions in SiC
por: Petersen, J W, et al.
Publicado: (1985)

Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes
por: On, Seungtae, et al.
Publicado: (2019)

Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study
por: Yamada, Yuichiro, et al.
Publicado: (2018)

FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization
por: Suh, Hoon Young, et al.
Publicado: (2023)

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition
por: Yang, Xiaomin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0br41ookt65ev85jrg59jcuve0